These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31530809)

  • 1. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.
    Hadoux X; Hui F; Lim JKH; Masters CL; Pébay A; Chevalier S; Ha J; Loi S; Fowler CJ; Rowe C; Villemagne VL; Taylor EN; Fluke C; Soucy JP; Lesage F; Sylvestre JP; Rosa-Neto P; Mathotaarachchi S; Gauthier S; Nasreddine ZS; Arbour JD; Rhéaume MA; Beaulieu S; Dirani M; Nguyen CTO; Bui BV; Williamson R; Crowston JG; van Wijngaarden P
    Nat Commun; 2019 Sep; 10(1):4227. PubMed ID: 31530809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer's disease.
    Lim JKH; Li QX; Ryan T; Bedggood P; Metha A; Vingrys AJ; Bui BV; Nguyen CTO
    Sci Rep; 2021 Mar; 11(1):6387. PubMed ID: 33737550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.
    Ong SS; Proia AD; Whitson HE; Farsiu S; Doraiswamy PM; Lad EM
    J Neurol; 2019 Jul; 266(7):1566-1577. PubMed ID: 30155741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status.
    Poudel P; Frost SM; Eslick S; Sohrabi HR; Taddei K; Martins RN; Hone E
    J Alzheimers Dis; 2024; 100(s1):S131-S152. PubMed ID: 39121128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APP
    Chibhabha F; Yang Y; Ying K; Jia F; Zhang Q; Ullah S; Liang Z; Xie M; Li F
    J Mater Chem B; 2020 Aug; 8(33):7438-7452. PubMed ID: 32662804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease.
    More SS; Beach JM; McClelland C; Mokhtarzadeh A; Vince R
    ACS Chem Neurosci; 2019 Nov; 10(11):4492-4501. PubMed ID: 31603648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal retinal layer changes in preclinical Alzheimer's disease.
    van de Kreeke JA; Nguyen HT; Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; van Berckel B; Lammertsma AA; Boomsma DI; Tan HS; Visser PJ; Verbraak FD
    Acta Ophthalmol; 2021 Aug; 99(5):538-544. PubMed ID: 33073531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients.
    Lemmens S; Van Craenendonck T; Van Eijgen J; De Groef L; Bruffaerts R; de Jesus DA; Charle W; Jayapala M; Sunaric-Mégevand G; Standaert A; Theunis J; Van Keer K; Vandenbulcke M; Moons L; Vandenberghe R; De Boever P; Stalmans I
    Alzheimers Res Ther; 2020 Nov; 12(1):144. PubMed ID: 33172499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer's Disease.
    Matei N; Leahy S; Blair NP; Burford J; Rahimi M; Shahidi M
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition.
    Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D
    J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
    Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.
    Marquié M; Valero S; Castilla-Marti M; Martínez J; Rodríguez-Gómez O; Sanabria Á; Tartari JP; Monté-Rubio GC; Sotolongo-Grau O; Alegret M; Pérez-Cordón A; Roberto N; de Rojas I; Moreno-Grau S; Montrreal L; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Abdelnour C; Gil S; Esteban-De Antonio E; Espinosa A; Ortega G; Lomeña F; Pavia J; Vivas A; Tejero MÁ; Gómez-Chiari M; Simó R; Ciudin A; Hernández C; Orellana A; Benaque A; Ruiz A; Tárraga L; Boada M;
    Alzheimers Res Ther; 2020 Mar; 12(1):37. PubMed ID: 32234080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
    Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
    J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.
    Golzan SM; Goozee K; Georgevsky D; Avolio A; Chatterjee P; Shen K; Gupta V; Chung R; Savage G; Orr CF; Martins RN; Graham SL
    Alzheimers Res Ther; 2017 Mar; 9(1):13. PubMed ID: 28253913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.
    Alber J; Bouwman F; den Haan J; Rissman RA; De Groef L; Koronyo-Hamaoui M; Lengyel I; Thal DR;
    Alzheimers Dement; 2024 Jan; 20(1):728-740. PubMed ID: 37917365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.